GlassScriptPhysician profile
Angela Hill
NPI 1992001689
$5,777.20
in general payments reported to CMS, 2019-2025
14 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.98 · 2022: $11.71 · 2023: $827 · 2024: $3,604 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,077 · Food and Beverage: $2,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,076.82 |
| Food and Beverage | $2,676.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,747.04 | 2023-2025 | Persona, Allograft, Tapestry |
| Arthrex, INC. | $662.71 | 2025 | |
| Conetic Solutions, INC. | $591.12 | 2025 | |
| Medtronic, INC. | $162.89 | 2023 | Aquamantys(Tm) |
| Depuy Synthes Sales INC. | $146.28 | 2023 | Monovisc, Orthovisc |
| Astrazeneca Pharmaceuticals LP | $88.64 | 2023 | Tezspire |
| Vericel Corporation | $83.63 | 2023-2024 | Maci |
| Novo Nordisk INC | $83.13 | 2022-2023 | Wegovy |
| Medical Device Business Services, INC. | $65.00 | 2023 | Stratafix |
| Boston Scientific Corporation | $35.74 | 2021-2023 | |
| Biocomposites INC | $33.76 | 2024 | |
| Solventum Corporation | $30.10 | 2024 | Spoton, Prevena, V.A.C. Veraflo |
| Sanara Medtech INC. | $25.70 | 2024 | Celleraterx |
| Osteoremedies, LLC | $21.46 | 2024 | Remedy Spectrum Gv Spacer, Remedy Spacer, Biobrush |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.